Company profile: Sadra Medical
1.1 - Company Overview
Company description
- Provider of minimally invasive alternatives to traditional surgical valve replacement, developing device-based therapies to facilitate and enhance treatment of aortic valve disease and improve patient care.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sadra Medical
Cardio Polymers
HQ: United States
Website
- Description: Provider of biocompatible polymer implant therapies and implantable devices to treat chronic heart failure, mitral valve regurgitation, and postoperative atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardio Polymers company profile →
Cardiokine
HQ: United States
Website
- Description: Provider of specialty pharmaceutical development for the prevention and treatment of cardiovascular diseases, including lixivaptan, an orally active vasopressin receptor antagonist for congestive heart failure patients with hyponatremia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardiokine company profile →
InteloMed
HQ: United States
Website
- Description: Provider of non-invasive, real-time cardiopulmonary monitoring solutions. Offers InteloMed TeleHealth Technology that uses facial scans during virtual consultations to deliver pulse and respiration metrics to clinicians. Engages in a NASA-supported project to develop non-contact monitoring for personnel and conducts an IRB-reviewed clinical study to validate its algorithms against traditional methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InteloMed company profile →
Third Pole
HQ: United States
Website
- Description: Provider of electric nitric oxide generation and delivery solutions for hospital, ambulatory, and home use. Products include eNOfit, a portable inhaled nitric oxide device for on-the-go treatment of severe COPD and ILD; eNOcare, an FDA-designated breakthrough hospital device for critical life-sustaining therapies; and on-demand iNO generation technology from air for bedside and portable therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Third Pole company profile →
Acesion Pharma
HQ: Denmark
Website
- Description: Provider of medical drugs for the treatment of atrial fibrillation, developing therapies that inhibit a heart cell ion channel. Offerings include AP30663, an intravenous drug for acute cardioversion to sinus rhythm with demonstrated efficacy in clinical trials, and AP31969, an oral drug for maintenance of sinus rhythm in patients with atrial fibrillation, currently in clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acesion Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sadra Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sadra Medical
2.2 - Growth funds investing in similar companies to Sadra Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sadra Medical
4.2 - Public trading comparable groups for Sadra Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →